Farah H. Amro

Shared mental models in postpartum hemorrhage management: A dual center multidisciplinary survey

Jennifer Hoayek, Yasmine Habli, Farah H. Amro, Alice O'Brien et autres

us (code pays fourni par la source)

Association between uterine artery Doppler velocimetry, placenta accreta spectrum, and depth of placental implantation

Elias Kassir, Edgar A. Hernandez‐Andrade, Donatella Gerulewicz-Vannini, Neha Agarwal et autres

Abstract Introduction We aim to evaluate uterine artery (UtA) Doppler velocimetry in patients at risk of placenta accreta spectrum (PAS). Methods Prospective cohort of patients referred to an academic referral center for suspected PAS. The left and right UtA were evaluated, and …

us (code pays fourni par la source)

The role of serial blood tests during expectant management of early preeclampsia with severe features

Zakaria Doughan, Yossi Bart, Joe Haydamous, Laura Diab et autres

Abstract Background Expectant management of early‐onset preeclampsia with severe features (<34 weeks’ gestation) requires close maternal surveillance. Although serial testing is routinely performed, recommendations regarding testing frequency vary across professional societies and the clinical utility and financial impact of frequent testing during …

us (code pays fourni par la source)

Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia (letter to the editor)

Farah H. Amro, B. M. Sibai

us (code pays fourni par la source)

26-A-13104-ACC DIAGNOSTIC HURDLES IN PERIPARTUM CARDIOMYOPATHY

Devangi Mahtani, Harnoor Mann, Laura Diab, Poyee P. Tung et autres

us (code pays fourni par la source)

Evaluating transvaginal ultrasound in placenta accreta spectrum scoring to determine placenta accreta spectrum severity

Neha Agarwal, Farah H. Amro, Sarah T. Mehl, Edgar A. Hernandez‐Andrade et autres

us (code pays fourni par la source)

In Reply

Farah H. Amro, Baha M. Sibai

us (code pays fourni par la source)

Aspirin 162 mg vs 81 mg for Preeclampsia Prophylaxis in High-Risk Obese Individuals: A Comparative Effectiveness Open-label Randomized Trial (ASPREO)

Farah H. Amro, Sean C. Blackwell, Claudia Pedroza, Sami Backley et autres

(Abstracted from Am J Obstet Gynecol 2025;232:315.e1–315.e8) Preeclampsia (PE) is a major contributor to poor maternal and neonatal outcomes, with obese pregnant individuals at increased risk for this hypertensive disorder of pregnancy. Although daily low-dose aspirin is widely recommended by professional societies …

us (code pays fourni par la source)

The Number of Previous Cesarean Deliveries and Severity of Placenta Accreta Spectrum: A Referral Center Experience

Neha Agarwal, Edgar A. Hernandez‐Andrade, Donatella Gerulewicz, Ramesha M. Papanna et autres

OBJECTIVE: The objective of this study was to evaluate the frequency of severe stages of placenta accreta spectrum (PAS) in relation to the number of previous cesarean deliveries (PCDs). DESIGN: We conducted a retrospective cohort study. SETTING: The study was carried out …

us (code pays fourni par la source)

Letter in Reply Re: Quantifying placenta accreta spectrum severity and its associated blood loss: a novel transvaginal ultrasound scoring system

Neha Agarwal, E. Hernandez‐Andrade, B. M. Sibai, Farah H. Amro et autres

us (code pays fourni par la source)

Cervical Length in Patients With Placenta Accreta Spectrum and Its Association With Unscheduled Delivery

Elias Kassir, Edgar A. Hernandez‐Andrade, Farah H. Amro, Cabrina I. Becker et autres

OBJECTIVES: To evaluate the association between cervical length (CL) and unscheduled delivery in patients with placenta accreta spectrum (PAS). METHODS: Retrospective cohort study of patients with suspected PAS from January 2018 to June 2024. Patients with suspected PAS underwent serial ultrasounds including …

us (code pays fourni par la source)

Leaving Placenta In Situ for Management of Placenta Accreta Spectrum Disorder

Farah H. Amro, Edgar A. Hernandez‐Andrade, Ramesha M. Papanna, Sarah T. Mehl et autres

OBJECTIVE: To evaluate maternal outcomes when leaving the placenta in situ for placenta accreta spectrum (PAS) according to planned surgical management. METHODS: We conducted a single-center retrospective cohort study of patients with PAS managed by leaving the placenta in situ from January …

us (code pays fourni par la source)